VIVEVE MEDICAL, INC.
VIVEHealthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | |
|---|---|---|---|---|---|---|
| Revenue | $6.4M | $5.5M | $6.6M | $18.5M | $15.3M | $7.1M |
| Operating income | −$21.6M | −$18.5M | −$30.7M | −$45.0M | −$33.7M | −$18.7M |
| Net income | −$22.0M | −$21.9M | −$42.5M | −$50.0M | −$37.0M | −$20.1M |
| Total assets | $25.9M | $16.6M | $47.5M | $46.8M | $36.1M | $14.5M |
| Total liabilities | $10.8M | $9.7M | $42.6M | $41.9M | $38.7M | $15.0M |
| Equity | $15.1M | $7.0M | $16.5M | $4.9M | −$2.6M | −$405,000 |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 10.3M | 10.0M | 46.4M | 31.2M | 10.7M | 59.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2021- Operating margin
- −335.4%
- Net margin
- −342.8%
- Return on equity
- −146.2%
- Return on assets
- −85.0%
- Return on capital (ROCE)
- −100.8%
- Liabilities / assets
- 41.9%
- Debt / equity
- 0.72×
- Book value / share
- $1.46
- Revenue growth (YoY)
- 17.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2021- Altman Z″ (distress)
- -30.08distress
- Accruals / assets
- −35.3%clean
- Beneish M-Score
- -4.63normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4,045 | 1.0 | -0.6% |
| Apr 30, 2026 | 4,068 | 3.9 | -0.3% |
| Apr 15, 2026 | 4,080 | 1.0 | -1.2% |
| Mar 31, 2026 | 4,129 | 1.0 | -1.0% |
| Mar 13, 2026 | 4,170 | 6.9 | -0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeJan 18, 2023
- Costs from exit or disposal · Delisting / listing-standard notice · Other material eventJan 17, 2023
- Regulation FD disclosureDec 15, 2022
- Delisting / listing-standard noticeDec 2, 2022
- Regulation FD disclosureDec 1, 2022
- Delisting / listing-standard noticeNov 23, 2022
- Results of operationsNov 10, 2022
- Regulation FD disclosureOct 4, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFORM 15-12GFeb 6, 2023
- EFFECTJan 30, 2023
- EFFECTJan 30, 2023
- EFFECTJan 30, 2023
- EFFECTJan 30, 2023
- EFFECTJan 30, 2023
- EFFECTJan 30, 2023
- EFFECTJan 30, 2023
- RWFORM RWJan 27, 2023
- POS AMFORM POS AMJan 27, 2023
- POS AMFORM POS AMJan 27, 2023
- POS AMFORM POS AMJan 27, 2023
- POS AMFORM POS AMJan 27, 2023
- POS AMFORM POS AMJan 27, 2023
- POS AMFORM POS AMJan 27, 2023
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.